Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock (LENZ)
CUSIP: 52635N103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 31,105,155
- Total 13F shares
- 19,863,850
- Share change
- +1,115,877
- Total reported value
- $573,239,116
- Price per share
- $28.87
- Number of holders
- 94
- Value change
- +$35,341,897
- Number of buys
- 53
- Number of sells
- 27
Report period
Q4 2024
Institutions
94
Top holders
10
LENZ full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52635N103
Recent filing periods:
Top shareholders of LENZ - LENZ Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
13%
|
4,178,823
|
$99,205,258 | — | 30 Sep 2024 | |
| Alpha Wave Global, LP |
13F
|
Company |
12%
|
3,612,211
|
$85,753,889 | — | 30 Sep 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
3.9%
|
1,208,473
|
$28,689,149 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,118,817
|
$26,560,716 | — | 30 Sep 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
3.3%
|
1,017,751
|
$24,161,409 | — | 30 Sep 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
3.1%
|
977,245
|
$23,199,796 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3%
|
930,021
|
$22,078,699 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.8%
|
864,942
|
$20,533,723 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
863,389
|
$20,496,855 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.5%
|
766,940
|
$18,207,156 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
448,631
|
$10,651,000 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
3/4/5
13F
|
10%+ Owner · Company |
1.1%
from 13F
|
8,538,446
|
$34,836,860 | — | 06 Jan 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
338,024
|
$8,026,764 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.93%
|
289,154
|
$6,864,516 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.66%
|
204,513
|
$4,855,139 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.45%
|
139,357
|
$3,308,335 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
129,639
|
$3,077,630 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
123,371
|
$2,928,828 | — | 30 Sep 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.39%
|
122,113
|
$2,898,963 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.34%
|
107,300
|
$2,547,302 | — | 30 Sep 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.27%
|
83,104
|
$1,972,889 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
64,941
|
$1,541,700 | — | 30 Sep 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
0.19%
|
60,000
|
$1,424,400 | — | 30 Sep 2024 | |
| Vivaldi Capital Management LP |
13F
|
Company |
0.19%
|
58,752
|
$1,394,772 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
54,379
|
$1,290,957 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
50,478
|
$1,198,347 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
49,266
|
$1,169,575 | — | 30 Sep 2024 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.13%
|
40,000
|
$949,600 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.11%
|
34,173
|
$811,588 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
33,054
|
$784,702 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.1%
|
31,309
|
$743,276 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
29,642
|
$703,701 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
28,310
|
$680,572 | — | 30 Sep 2024 | |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
|
Company |
0.09%
|
27,504
|
$652,945 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
25,507
|
$605,536 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.08%
|
24,621
|
$584,502 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.08%
|
23,875
|
$566,793 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.07%
|
23,130
|
$549,106 | — | 30 Sep 2024 | |
| KELLEHER FINANCIAL ADVISORS |
13F
|
Company |
0.07%
|
20,773
|
$493,151 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
19,851
|
$471,263 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
17,654
|
$419,097 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
16,463
|
$390,832 | — | 30 Sep 2024 | |
| Rinkey Investments |
13F
|
Company |
0.05%
|
15,186
|
$360,516 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
12,654
|
$300,406 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
12,027
|
$285,521 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
10,357
|
$246,000 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
9,346
|
$221,874 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
9,147
|
$217,150 | — | 30 Sep 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
7,672
|
$182,133 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
6,909
|
$164,020 | — | 30 Sep 2024 |
Institutional Holders of LENZ Therapeutics, Inc. - Common Stock (LENZ) as of Q4 2024
As of 31 Dec 2024,
LENZ Therapeutics, Inc. - Common Stock (LENZ) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,863,850 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Alpha Wave Global, LP, VANGUARD GROUP INC, BlackRock, Inc., 72 Investment Holdings, LLC, Samsara BioCapital, LLC, SECTORAL ASSET MANAGEMENT INC, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, and Point72 Asset Management, L.P..
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
78
Q4 2024 holders
94
Holder diff
16
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.